News
RDHL
5.51
-1.22%
-0.07
Weekly Report: what happened at RDHL last week (0106-0110)?
Weekly Report · 1d ago
Weekly Report: what happened at RDHL last week (1230-0103)?
Weekly Report · 01/06 10:30
Weekly Report: what happened at RDHL last week (1223-1227)?
Weekly Report · 12/30/2024 10:26
Weekly Report: what happened at RDHL last week (1216-1220)?
Weekly Report · 12/23/2024 10:30
Weekly Report: what happened at RDHL last week (1209-1213)?
Weekly Report · 12/16/2024 10:31
RedHill Biopharma's Opaganib Demonstrates Protective Activity Against GI-ARS, Paving The Way for Future FDA Approval vVa Animal Rule
Benzinga · 12/10/2024 12:30
RedHill Biopharma Advances Opaganib for GI-ARS Treatment
TipRanks · 12/10/2024 12:28
RedHill Biopharma’s opaganib shows radioprotective activity in study
TipRanks · 12/10/2024 12:17
RedHill Biopharma Announced Results From New In Vivo Studies Of Opaganib For Gastrointestinal Acute Radiation Syndrome, Undertaken As Part Of The U.S. Government's Radiation And Nuclear Countermeasures Program Contract That Further Confirms Opaganib's Protective Activity In Animal Models
Benzinga · 12/10/2024 12:14
Weekly Report: what happened at RDHL last week (1202-1206)?
Weekly Report · 12/09/2024 10:30
RedHill Biopharma Wins $8 Million Court Judgment
TipRanks · 12/02/2024 12:26
RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court
TipRanks · 12/02/2024 12:18
Redhill Biopharma Has Been Awarded Approximately $8M Plus Costs In A Summary Judgment By The Supreme Court Of The State Of New York, New York County, In Its Legal Proceedings Against South Korea-based Kukbo
Benzinga · 12/02/2024 12:05
Weekly Report: what happened at RDHL last week (1125-1129)?
Weekly Report · 12/02/2024 10:30
Weekly Report: what happened at RDHL last week (1118-1122)?
Weekly Report · 11/25/2024 10:25
Weekly Report: what happened at RDHL last week (1111-1115)?
Weekly Report · 11/18/2024 10:23
Weekly Report: what happened at RDHL last week (1104-1108)?
Weekly Report · 11/11/2024 10:31
Weekly Report: what happened at RDHL last week (1028-1101)?
Weekly Report · 11/04/2024 10:30
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
TipRanks · 10/28/2024 11:29
Weekly Report: what happened at RDHL last week (1021-1025)?
Weekly Report · 10/28/2024 10:24
More
Webull provides a variety of real-time RDHL stock news. You can receive the latest news about Redhill Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.